2022
DOI: 10.1016/j.aanat.2021.151818
|View full text |Cite
|
Sign up to set email alerts
|

Macrophage-activating lipoprotein (MALP)-2 impairs the healing of partial tendon injuries in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…MALP-2, a synthetically devised lipopeptide, functions as a ligand and agonist for TLR2 and TLR6 33 . Current literature suggests that derivatives of MALP-2, along with their analogues, show promise in addressing diseases accompanied by chronic in ammation 32,34 . Furthermore, MALP-2 has been documented for its potency in activating immune cells across various sites 32,35 , and kindling in ammatory signaling pathways 28,32 , thus suggesting its viability as a radioprotective agent in irradiated mice.…”
Section: Discussionmentioning
confidence: 99%
“…MALP-2, a synthetically devised lipopeptide, functions as a ligand and agonist for TLR2 and TLR6 33 . Current literature suggests that derivatives of MALP-2, along with their analogues, show promise in addressing diseases accompanied by chronic in ammation 32,34 . Furthermore, MALP-2 has been documented for its potency in activating immune cells across various sites 32,35 , and kindling in ammatory signaling pathways 28,32 , thus suggesting its viability as a radioprotective agent in irradiated mice.…”
Section: Discussionmentioning
confidence: 99%
“…Topical application of MALP-2 in mice revealed a decrease in biomechanical stiffness, a significant increase in HO-1 expression in the tendons, and a reduction in cyclin D expression, all of which delayed the healing of the injured tendons. It is likely that MALP-2 stimulated increased intracellular pressure and inhibited cell proliferation in the injured tendon, a naturally dystrophic tissue ( 90 ). Thus, MALP-2 is not applicable in the treatment of tendon injury, and perhaps MALP-2 has unexpected applications in more tissues, which will need to be explored later.…”
Section: Immunological Application Of Malp-2mentioning
confidence: 99%
“…The Achilles tendon was the focus of 5 out of 8 articles, and partial transection injury was the most commonly studied (13)(14)(15)(16). Other tendons examined in the remaining 3 articles included rotator cuff and flexor digitorum longus (17)(18)(19). In general, most of these studies reported a limited number of parameters (in some cases only a single parameter was reported), and how these parameters were selected was unclear.…”
Section: Introductionmentioning
confidence: 99%